- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02561715
Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's
Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study to Examine the Effects of Anosognosia on Self-Reported Quality of Life for People With Parkinson's
Anosognosia is a recognised condition for people with Parkinson's, and is the result of physiological damage on brain structure.
Surgical Parkinson Disease Nurse Specialists have noticed that when reviewing the pre-surgery videos 12 months post-DBS, patients have forgotten and are shocked at how bad their symptoms were prior to surgery (personal communication), which may not be reflected in the change in QoL reported.
This lack of awareness, while possibly helpful in everyday life, may lead to effective treatments looking ineffective, or the benefits in QoL of effective treatment appearing reduced. This confound may not only reduce the apparent effectiveness but also the related cost-effectiveness of treatment. As cost-effectiveness is determined by both size and longevity of an effect, current methods of capturing these data may be suboptimal.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The overarching aim of this project is to identify coping mechanisms and pathological lack of self-awareness and the impact they are likely to have on patient reported quality of life (QoL) outcome measures for a chronic condition.
This will be an observational study, a case series of approx. 10 to 20 patients. These patients will be recruited over a 6 month period from the Queen Elizabeth Hospital, Birmingham and will be informed of the study during their routine pre-surgical visit.
Patients will be eligible if they are about to undergo DBS at Queen Elizabeth Hospital. If the participant has a carer, who is also willing to participate, they may also join the study. Patients will be excluded if they are unable to complete questionnaires in English.
Once recruited and following consent, a patient will complete a brief battery of questionnaires both self-reported and clinician rated prior to surgery and at their 6 month post op visit.
Study Type
Contacts and Locations
Study Locations
-
-
-
Birmingham, United Kingdom, B15 2TT
- Queen Elizabeth Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of Parkinson's as defined by the UK PDS Brain Bank Criteria
Exclusion Criteria:
- Unable to complete questionnaires in English.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement of ability to recall extent of condition
Time Frame: 9 months
|
Person with Parkinson's specific quality of life using the Parkinson's Disease Questionnaire for both participant and carer.
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinician's Rating Scale for Evaluating Impaired Self Awareness and Denial of Disability after Brain Injury adapted for use with PD patients.after Brain Injury, adapted for use with Parkinson's Disease patients
Time Frame: 9 months
|
Participants self-awareness of their Parkinson's
|
9 months
|
|
Patient Generated Index
Time Frame: 9 months
|
Quality of life measure
|
9 months
|
|
Abnormal Involuntary Movement Scale
Time Frame: 9 months
|
Occurrence of tardive dyskinesia
|
9 months
|
|
Patient Competency Rating Scale
Time Frame: 9 months
|
Evaluation of self-awareness following traumatic brain injury
|
9 months
|
|
Grooved peg board test
Time Frame: 9 months
|
Measuring motor performance
|
9 months
|
|
The tapping test
Time Frame: 9 months
|
Measuring motor control
|
9 months
|
|
Unified Parkinson's Disease Rating Scale
Time Frame: 9 months
|
Rating the extent of the participant's Parkinson's
|
9 months
|
|
Mini Mental State Exam
Time Frame: 9 months
|
Measure of cognitive impairment
|
9 months
|
|
Parkinson's' Disease Questionnaire
Time Frame: 9 months
|
PDQ-39 (Carer)
|
9 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hardev Pall, MD, Queen Elizabeth Medical Centre, Birmingham, UK
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RG_14-096
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anosognosia
-
Institut National de la Santé Et de la Recherche...Completed
-
Gazi UniversityCompletedHemiplegia | Anosognosia | Right Hemispheric Stroke | Hemispatial NeglectTurkey
-
University of Geneva, SwitzerlandUniversity Hospital, GenevaNot yet recruitingStroke | Anosognosia | Neglect, Hemispatial
-
Centre for Addiction and Mental HealthScion NeuroStimTerminatedSchizophrenia | AnosognosiaCanada
-
Laureate Institute for Brain Research, Inc.Tulsa Day CenterCompletedSchizophrenia | Bipolar Disorder | AnosognosiaUnited States
-
University of Wisconsin, MadisonCompletedMild Cognitive Impairment | Alzheimer's Disease | AnosognosiaUnited States
-
University of ExeterRoyal Devon University Healthcare NHS Foundation TrustNot yet recruitingStroke | Anosognosia
-
María Rodríguez BailónUniversidad de GranadaCompletedAnosognosia | Brain Damage
-
María Rodríguez BailónUniversidad de GranadaCompletedExecutive Dysfunction | Anosognosia | Brain DamageSpain
-
Gazi UniversityCompletedStroke | Anosognosia | Neglect, Hemispatial | Neurobehavioral ProblemsTurkey
Clinical Trials on Questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University Hospital, ToulouseNot yet recruiting
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
Nova Scotia Health AuthorityNot yet recruitingStroke | Amputation | Spinal Cord Injury | Caregivers | Wheelchair Users | Wheelchair Service ProvidersCanada
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast Cancer | MetastasisUnited States
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States